Leebeek FWG - Search Results

1

Antithrombin levels are associated with the risk of first and recurrent arterial thromboembolism at a young age.

Croles FN, Van Loon JE, Dippel DWJ, De Maat MPM, Leebeek FWG. Croles FN, et al. Among authors: leebeek fwg. Atherosclerosis. 2018 Feb;269:144-150. doi: 10.1016/j.atherosclerosis.2018.01.014. Epub 2018 Jan 16. Atherosclerosis. 2018. PMID: 29366986 Free article.

2

PLA1/A2 polymorphism of the platelet glycoprotein receptor IIb/IIIa in young patients with cryptogenic TIA or ischemic stroke.

van Goor ML, Gómez García E, Brouwers GJ, Leebeek FW, Koudstaal PJ, Dippel DW. van Goor ML, et al. Thromb Res. 2002 Oct 1;108(1):63-5. doi: 10.1016/s0049-3848(02)00356-0. Thromb Res. 2002. PMID: 12586134

3

Association between thrombin-activatable fibrinolysis inhibitor (TAFI) and clinical outcome in patients with unstable angina pectoris.

Brouwers GJ, Leebeek FW, Tanck MW, Wouter Jukema J, Kluft C, de Maat MP. Brouwers GJ, et al. Thromb Haemost. 2003 Jul;90(1):92-100. Thromb Haemost. 2003. PMID: 12876631

4

What is the lowest dose of aspirin for maximum suppression of in vivo thromboxane production after a transient ischemic attack or ischemic stroke?

Dippel DW, Van Kooten F, Leebeek FW, van Vliet HH, Mehicevic A, Li SS, Koudstaal PJ. Dippel DW, et al. Cerebrovasc Dis. 2004;17(4):296-302. doi: 10.1159/000077340. Epub 2004 Mar 15. Cerebrovasc Dis. 2004. PMID: 15026612 Clinical Trial.

5

The plasminogen activator inhibitor (PAI-1) 4G/5G promoter polymorphism and PAI-1 levels in ischemic stroke. A case-control study.

van Goor ML, Gómez García E, Leebeek F, Brouwers GJ, Koudstaal P, Dippel D. van Goor ML, et al. Thromb Haemost. 2005 Jan;93(1):92-6. doi: 10.1160/TH04-09-0560. Thromb Haemost. 2005. PMID: 15630497

6

Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity.

Lisman T, Bongers TN, Adelmeijer J, Janssen HL, de Maat MP, de Groot PG, Leebeek FW. Lisman T, et al. Hepatology. 2006 Jul;44(1):53-61. doi: 10.1002/hep.21231. Hepatology. 2006. PMID: 16799972

7

High von Willebrand factor levels increase the risk of first ischemic stroke: influence of ADAMTS13, inflammation, and genetic variability.

Bongers TN, de Maat MP, van Goor ML, Bhagwanbali V, van Vliet HH, Gómez García EB, Dippel DW, Leebeek FW. Bongers TN, et al. Stroke. 2006 Nov;37(11):2672-7. doi: 10.1161/01.STR.0000244767.39962.f7. Epub 2006 Sep 21. Stroke. 2006. PMID: 16990571

8

Genetic variation in thrombin-activatable fibrinolysis inhibitor (TAFI) is associated with the risk of splanchnic vein thrombosis.

de Bruijne EL, Darwish Murad S, de Maat MP, Tanck MW, Haagsma EB, van Hoek B, Rosendaal FR, Janssen HL, Leebeek FW; Liver and Thrombosis Study Group. de Bruijne EL, et al. Thromb Haemost. 2007 Feb;97(2):181-5. Thromb Haemost. 2007. PMID: 17264944

9

Prothrombotic coagulation abnormalities in patients with paraprotein-producing B-cell disorders.

Auwerda JJ, Sonneveld P, de Maat MP, Leebeek FW. Auwerda JJ, et al. Clin Lymphoma Myeloma. 2007 Jul;7(7):462-6. doi: 10.3816/clm.2007.n.027. Clin Lymphoma Myeloma. 2007. PMID: 17875234

10

Platelet receptor P2RY12 haplotypes predict restenosis after percutaneous coronary interventions.

Rudez G, Pons D, Leebeek F, Monraats P, Schrevel M, Zwinderman A, de Winter R, Tio R, Doevendans P, Jukema W, de Maat M. Rudez G, et al. Hum Mutat. 2008 Mar;29(3):375-80. doi: 10.1002/humu.20641. Hum Mutat. 2008. PMID: 18175333

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

393 results

Search Page

Filters